Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • GenePeeks Launches NGS Platform To Assess Potential Disorders In Children

    Diagnostics World | GenePeeks has launched its proprietary next-generation screening platform, which has the ability to assess the risk of conceiving a child with any one of more than 1,000 heritable genetic diseases.

    Feb 14, 2017
  • New Molecular Markers Fuel Diagnostic Development

    BioPharma Dive | While they may never command the eye-popping $250,000 price tag that some newer drugs do, there are still many experts who think there could be a Cinderella story for certain types of in vitro diagnostics.

    Feb 14, 2017
  • Quest Diagnostics And Veracyte Partner Up For Cancer Testing

    Diagnostics World Brief | Quest Diagnostics has recently entered into an agreement with genomic diagnostics company Veracyte, for the extended access of the latter's laboratory-developed test, Afirma Gene Expression Classifier.

    Feb 10, 2017
  • MDxHealth Awarded US Department Of Veterans Affairs Contract For ConfirmMDx Testing

    Diagnostics World Brief | MDxHealth today announced that it has been awarded a US Government Services Administration supply contract to use ConfirmMDx for Prostate Cancer within the Department of Veterans Affairs.

    Feb 8, 2017
  • A1C Test Could Misdiagnose Diabetes In African-Americans

    NPR.org | People with sickle cell trait, which includes about 10% of African-Americans, can get higher readings on a common blood glucose test. That could lead to diabetes treatment they don't need.

    Feb 7, 2017
  • Gut Check: The Role Of The Microbiome In Parkinson's Disease

    Diagnostics World | After struggling to treat Parkinson’s for centuries, researchers are reimagining the illness and pursuing a mind-gut connection that could lead to new and improved treatments.

    Feb 6, 2017
  • The IVD Industry Today

    Diagnostics World | Harry Glorikian’s new book, Commercializing Novel IVDs: A Comprehensive Manual for Success, provides an overview of the IVD landscape today, from IVD conception through commercialization.

    Feb 3, 2017
  • ACMG Weighs In On Gene Editing American Council On Science And Health

    American Council On Science And Health | The ACMG recently published a statement discussing genome editing in clinical genetics. They discuss various topics, such as the limitations of genome editing technologies, and technical concerns.

    Feb 1, 2017
  • This Health App Gets Indians Connected With Medical Specialists In Just 30 Minutes

    Forbes | Aiming to tackle the severe shortage of specialist doctors in India, the 27-year olds behind the DocsApp platform promise a consultation with a doctor within 30 minutes of logging on to their app (with a little AI help).

    Jan 30, 2017
  • Illumina Debuts VeriSeq Analysis Software With 48 Samples

    Diagnostics World Brief | Illumina today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq NIPT Analysis Software for clinical laboratories in the European Union.

    Jan 30, 2017
  • Illumina, Mobidiag, Omicia, And More: News From January 2017

    Diagnostics World Brief | News, products, and partnerships from around the diagnostics community including news from Illumina, Mobidiag, Omicia, and more.

    Jan 26, 2017
  • Two Pore Guys Seek Assay For Platform

    Diagnostics World | Newly out of stealth mode, Two Pore Guys is seeking diagnostic partners for its silicon pore detection platform.

    Jan 23, 2017
  • Genetic Testing Offers New Hope for Children with Brain Cancer

    MIT Technology Review | More than half of pediatric cancer patients have genetic faults that could affect their diagnosis or be targeted by drugs.

    Jan 23, 2017
  • Alexa Cortana And Siri Are About To Diagnose Your Health

    Forbes | Diagnosing serious diseases and conditions via just listening to voice snippets is possible. Are we about to get a doctor in every room thanks to Alexa, Siri and Google Home?

    Jan 23, 2017
  • Next Generation Troponin T Test From Roche Cleared By FDA

    Diagnostics World Brief | Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT blood test for patients with a suspected heart attack. Roche is now the first IVD company in the U.S. to provide the next generation Troponin testing for patients as an aid in the diagnosis of myocardial infarction.

    Jan 20, 2017
  • Nanoparticles For Rapid Chemotherapeutic Selection And Beyond

    Diagnostics World | Researchers have recently developed technology that is able to screen anticancer drugs inside tumors for their therapeutic potency. 100 nanometer liposomes were loaded with minuscule amounts of chemotherapeutics and synthetic DNA strands, or “barcodes,” that identify the therapeutics.

    Jan 19, 2017
  • Forward: Reinventing Healthcare With A Dose Of Apple, Netflix, And AI

    Forbes | Google veteran Adrian Aoun has raised more than $30 million to create a new kind of tech-enabled medical practice that hopes to deliver better care at lower cost.

    Jan 17, 2017
  • A Woman In Nevada Died From An Unstoppable Superbug

    MIT Technology Review | A strain of bacteria resistant to 26 different antibiotics killed a woman in Nevada, a stark warning that humanity continues to lose ground in the fight against antibiotic resistance.

    Jan 13, 2017
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79 (current)
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy